Omada Health (OMDA) CFO Steven Cook Sells $378K of Stock

Steven Cook sold shares valued at $378,207 in a planned transaction.

Reviewed by automated data checks against the source filing. How we make and check alerts

Steven Cook, Chief Financial Officer at Omada Health, Inc. ($OMDA), sold 17,950 shares at an average price of $21.07, worth about $378,206.50, on June 29, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.

Since the trade, $OMDA is up 5.5% after 1 week, down 9.5% after 1 month and down 18.6% to date (from the $21.67 close on Jun 29, 2026).

Find the original: OMDA Form 4 filings on SEC EDGAR

OMDA Omada Health, Inc.
$17.63 +18.32% year to date
Daily close · Oct 16, 2026

Key Points

  • On June 29, 2026, Steven Cook, Omada Health's CFO, sold 17,950 shares at $21.07 each, totaling $378,207.
  • The company's stock closed at $21.95 on the day of publication, showing a strong position after a recent run.
  • Analysts maintain a consensus 'Buy' rating for Omada Health, with a mean price target of $28.42.

Get $OMDA trade alerts by text

We text you when insiders, Congress or big funds trade $OMDA. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Omada Health, Inc. alert may contain errors. Disclosures

Inside Steven Cook's Recent Sale

Steven Cook, the Chief Financial Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 17,950 shares on June 29, 2026. This planned sale was valued at about $378,207, with shares sold at an average price of $21.07. This transaction adds to Cook's previous insider activities, which included selling 33,000 shares just days earlier on June 26.

Recent Insider Activity

Cook's recent sell comes after he parted with 33,000 shares valued at $656,370 on June 26, 2026. Earlier, on June 24, he sold 2,600 shares for about $49,452. Overall, these sales indicate a significant level of insider movement, as Cook has consistently shed shares in the past weeks, including a sale of 6,800 shares for $117,164 on June 15, 2026. Such activity can reflect various strategic decisions, and in this case, the sales were part of a planned strategy.

Stock Performance and Market Context

The stock of Omada Health was priced at $21.95 on the publication date, reflecting a strong position in the market following its recent performance. This price is well above the company's 52-week low of $10.28, showcasing significant growth over the past year. The stock has been trading near its 50-day moving average of $22.28, suggesting stable recent movements.

Analysts Set New Price Targets

Several analysts continue to voice confidence in Omada Health. On October 14, 2026, Freedom Capital Markets maintained a 'Buy' rating with a price target of $35. Other firms like Needham and Barclays also express positive sentiment with targets of $28 and $27, respectively. The consensus rating remains 'Buy' with a target mean price of approximately $28.42 based on 12 analyst opinions.

Overview of Omada Health

Omada Health, Inc. provides virtual care programs in the healthcare sector, focusing on issues like diabetes and hypertension management. By blending technology with care, it caters to various clients, including employers and health plans. The recent insider sales could indicate ongoing adjustments as the company prepares for its next earnings report.

What's Ahead for Omada Health, Inc.

Investors should keep an eye on the upcoming earnings report set for November 5, 2026. It's also important to remember that the reported insider activity reflects past transactions and may not represent current holdings. As Omada Health continues to evolve, further developments in insider trades and analyst ratings will be key indicators to watch.

Source: Steven Cook's Form 4 filing on $OMDA (Jun 29, 2026). Find the original filing: OMDA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $OMDA trade alerts by text